Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

NCT02328040 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Placebo and Insulin monotherapy via CL
DRUG: Sitagliptin and insulin/novolog via CL

Sponsor

Albert Einstein College of Medicine

Collaborators

[object Object]